{
    "id": 18073,
    "cites": 37,
    "cited_by": 2,
    "reference": [
        "Bate, Roger, Hess, K, Mooney, L. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Medicine Registration and Medicine Quality: A Preliminary Analysis of Key Cities in Emerging Markets\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d, Research and Reports in Tropical Medicine, December 2010, vol 1. Pp 89-93, doi 10.2147/RRTM. S15199.",
        "Bar-Isaac, Heski and Steve Tadelis (2008) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Seller Reputation\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Foundations and Trends in Microeconomics, 4(4).",
        "Brickley, James A.; Susan Feng Lu; and Gerard J. Wedig (2012) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Ownership, Branding and Multiple Audience Concerns: Evidence from Nursing Homes.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Rochester University working paper.",
        "Brickley, James A.; J.S. Linck and C.W. Smith (2003) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Boundaries of the Firm: Evidence from the Banking Industry\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Financial Economics, 18(2): 401-20.",
        "Bate, Roger; Ginger Zhe Jin and Aparna Mathur (2011) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Does Price Reveal Poor-Quality Drugs? Evidence from 17 Countries\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d the Journal of Health Economics, 30(6): 1150-1163.",
        "Bate, Roger (2012) Phake: the Deadly World of Falsified and Substandard Medicines, Publisher: American Enterprise Institute Press. Bate, Roger. et al \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Substandard and Falsified Anti-Tuberculosis Drugs - A Preliminary Field Analysis.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The International Journal of Tuberculosis and Lung Disease. forthcoming.",
        "Bate R, Tren R, Hess, K, Mooney, L, Porter, K, Pilot study comparing technologies to test for substandard drugs in field settings, African Journal of Pharmacy and Pharmacology Vol.3(4), pp.165-170 April, 2009.",
        "Bate R, Tren R, Mooney L, et al. Pilot Study of Essential Drug Quality in Two Major Cities in India. PLoS ONE. 2009;4(6): e6003.;doi:10.1371/journal.pone.0006003.",
        "Bate R, Hess K. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Anti-malarial drug quality in Lagos and Accra \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c a comparison of various quality assessments.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Malar J. 2010;9:157. doi:10.1186/1475-2875-9-157.",
        "Bate R, Coticelli P, Tren R, Attaran A. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Antimalarial drug quality in the most severely malarious parts of Africa \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c A six country study.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d PLoS ONE. 2008;3(5): e2132. doi:10.1371/journal.pone.0002132.",
        "Bate, Roger, Richard Tren, and Jasson Urbach. Still Taxed to Death: An Analysis of Taxes and Tariffs on Medicines, Vaccines and Medical Devices. Washington, DC: AEI-Brookings Joint Center for Regulatory Studies, 2006.",
        "Bate, Roger, Emily Putze, Sarah Naoshy, Alexandra McPherson, and Lorraine Mooney. Drug Registration - a necessary but not sufficient condition for good quality drugs \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c a preliminary analysis of 12 countries. Africa Fighting Malaria Working Paper (Africa Fighting Malaria), 2010.",
        "World Health Organization (2011), \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Report of the Working Group of Member States on Substandard/Spurious/Falsely-Labelled/Falsified/Counterfeit Medical Products\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d, March 11, 2011, accessed at http://apps.who.int/gb/ssffc/pdf_files/A_SSFFC_WG5-en.pdf on Oct. 11,",
        "World Health Organization (2010), \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Medicines: spurious/falsely-labelled/ falsified/counterfeit (SFFC) medicines\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d, fact sheet 275, accessed at http://www.who.int/mediacentre/factsheets/fs275/en/index.html, on April 22, 2012.",
        "Wolinsky, Asher. Prices as Signals of Product Quality.The Review of Economic Studies Vol 50 No.4, 1983: 647-658.",
        "USAID (2009) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Growing Threat of Substandard and Counterfeit Medicines in Developing Countries Addressed by New USAID-USP Cooperative Agreement\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d USAID press release, accessed at http://www.usaid.gov/press/releases/2009/pr091026_1.html, on April 22, 2012.",
        "Qian, Yi (2012) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Brand Management and Strategies Against Counterfeits\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d, Northwestern University working paper.",
        "Png, I. P. L. and Reitman, D. (1995, Why Are Some Products Branded and Others Not. Journal of Law & Economics, 38(1), pp. 207-24.",
        "Qian, Yi (2008) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Impacts of Entry by Counterfeiters\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics 123(4): 1577-1609.",
        "Pincock, S. (2003) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093WHO tries to tackle problem of counterfeit medicines in Asia\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d British Medical Journal 327: 1126.",
        "Oxfam, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Eye on the Ball Medicine regulation \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c not IP enforcement \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c can best deliver quality medicines\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d 143 Oxfam Brief Paper, February 2, 2011.",
        "Newton PN, Amin AA, Bird C, Passmore P, Dukes G, et al. (2011) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Primacy of Public Health Considerations in Defining Poor Quality Medicines.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d PLoS Med 8(12): e1001139. doi:10.1371/journal.pmed.1001139.",
        "http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0020100 Newton, Paul N. Green, Michael D; Fernandez, Facundo M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Impact of poor-quality medicines in the \u00c3\u00a2\u00e2\u0082\u00ac\u00cb\u009cdeveloping\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 world.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Trends in Pharmacological Sciences. Vol. 31. Issue 3, March 2010, Pgs. 99-101. http://www.sciencedirect.com/science/article/pii/S016561470900203X Newton, Paul N. Green, Michael D; Fernandez, Facundo M. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Impact of poor-quality medicines in the \u00c3\u00a2\u00e2\u0082\u00ac\u00cb\u009cdeveloping\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 world.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Trends in Pharmacological Sciences. Vol. 31. Issue 3, March 2010, Pgs. 99-101. http://www.sciencedirect.com/science/article/pii/S016561470900203X.",
        "Newton, Paul N; Cockburn, Robert; Agyarko, E Kyeremateng; Akunyili, Dora; White, Nicholas J. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d PLoS Medicine. March 14, 2005.",
        "Nayyar, Gaurvika M L; Breman, Joel G; Newton, Paul N; Herrington, James. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Lancet. Vol. 12, June 2012.",
        "Milgrom, Paul and J. Roberts (1986) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Price and Advertising Signals of Product Quality\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy 94: 796-821.",
        "Mazzeo, Michael J. (2004) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Retail Contracting and Organizational Form: Alternatives to Chain Affiliation in the Motel Industry\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Economics & Management Strategy, 13(4): 599615.",
        "Maschler, M. (1966) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A Price Leadership Method for Solving the Inspector\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Non-constant Sum Game\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Naval Research Logistics Quarterly 13: 11-33.",
        "Luca, Michael (2012) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Reviews, Reputation, and Revenue: The Case of Yelp.com\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Harvard Business School working paper.",
        "Leland, Hayne E. (1979) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Quacks, Lemons, and Licensing: A Theory of Minimum Quality Standards\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 87(6): 1328-1346.",
        "Klein, Benjamin and K.B. Leffler (1981) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Role of Market Forces in Assuring Contractual Perforamnce\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Political Economy, 89(4): 615-41.",
        "Kelesidis, Theodore; Iosif Kelesidis; Petros I. Rafailidis and Matthew E. Falagas (2007) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Counterfeit or Substandard Antimicrobial Drugs: A Review of the Scientific Evidence\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Antimicrobial Chemotherapy 60: 214-236.",
        "Jin, Ginger Zhe and Phillip Leslie (2009) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Reputational Incentives for Restaurant Hygiene\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Economic Journal \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c Microeconomics, 1(1): 237-67.",
        "Fitzpatrick Christopher and Katherine Floyd (2012) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A systematic review of the cost and cost effectiveness of treatment for multidrug resistant tuberculosis\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d, Pharmacoeconomics, (1):6380.",
        "Dresher, M. (1962) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093A Sampling Inspection Problem in Arms Control Agreements: A GameTheoretic Analysis\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Memorandum RM-2972-ARPA, The RAND Corporation, Santa Monica, California.",
        "Cockburn, R, PN Newton, EK Agyarko, D Akunyili, and NJ White. The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers. PLoS Medicine 2(4): e100, 2005.",
        "Caudron, J.M.; N. Ford; M. Henkens; C. Mace; R. Kiddle-Monroe and J. Pinel (2008) \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Substandard medicines in resource-poor settings: a problem that can no longer be ignored\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Tropical Medicine and International Health, 13(8): 1062-1072."
    ]
}